The metabolic effect of Momordica charantia cannot be determined based on the available clinical evidence: a systematic review and meta-analysis of randomized clinical trials. [PDF]
Laczkó-Zöld E +6 more
europepmc +1 more source
Clinical application of <i>Momordica charantia</i> (Bitter Melon) for reducing blood sugar in type 2 diabetes mellitus. [PDF]
Dahlquist A +3 more
europepmc +1 more source
Genotype × environment interaction studies in monoecious and gynoecious bitter gourd (Momordica charantia L.) genotypes for stability using multi-model based approach. [PDF]
Moharana DP +11 more
europepmc +1 more source
Restorative effects of Momordica charantia extract on cerebellar GFAP and NGF expression in pregnant diabetic rats and their offspring. [PDF]
Abou-El-Naga AM +6 more
europepmc +1 more source
Therapeutic Potential of Momordicine I from Momordica charantia: Cardiovascular Benefits and Mechanisms. [PDF]
Kao PF +4 more
europepmc +1 more source
Bioassay-guided isolation of leishmanicidal cucurbitacins from Momordica charantia. [PDF]
Marques MCS +4 more
europepmc +1 more source
Multi-omics study uncovered key differences in taste and nutritional quality among three distinct bitter gourd (<i>Momordica charantia</i> L.) cultivars. [PDF]
Xue S +8 more
europepmc +1 more source

